New York (December 18th, 2012) - Geron Corporation (NASDAQ: GERN), a biopharmaceutical company engaged in the development of therapies for cancer, is seeing pullback in trading today after rallying for a week.
GERN had been rallying since December 10 after the company presented positive results from Phase 2 study of Imetelstat in essential thrombocythemia at the American Society of Hematology Annual Meeting. The rally has ended in trading today, with the stock falling more than 2% to $1.66 in mid-day trading. In the last five trading sessions, GERN has gained more than 56%.
GERN has slipped after facing resistance at $1.75. The stock has struggled to break through this level in the past. If GERN can break through this level then the stock could post significant gains.
Find out what could be expected from GERN in the very short term by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=GERN
Facebook Inc. (NASDAQ: FB), the social networking giant, is up sharply in mid-day trading today, reversing some of the losses from the previous two trading sessions. At last check, FB was trading 1.76% higher at 27.22 on volume of 21.39 million, which is significantly below the daily average volume of 73.65 million. FB is still down more than 3.6% in the last three trading sessions.
FB rallied last month after posting impressive results. The stock rose from around $19 to nearly $28. However, the stock has struggled to break through $28 for couple of weeks now. If FB can break through this level then the rally could once again resume. FB is still trading well below its IPO price of $38.
Find out more about FB by getting the free full report here:
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
WALL STREET REPORT
Leave a comment...